Xenon Pharmaceuticals, Inc. (XENE)
43.04
-0.75
(-1.71%)
USD |
NASDAQ |
Mar 04, 16:00
43.09
+0.05
(+0.12%)
After-Hours: 17:35
Xenon Pharmaceuticals Cash from Investing (Quarterly) : 60.79M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | -36.89M |
| Oncolytics Biotech, Inc. | -0.0051M |
| Edesa Biotech, Inc. | 0.00 |
| Lexaria Bioscience Corp. | -0.0051M |
| ProMIS Neurosciences, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -79.06M |
| Cash from Financing (Quarterly) | 113.73M |
| Free Cash Flow | -280.51M |
| Free Cash Flow Per Share (Quarterly) | -0.9906 |
| Free Cash Flow to Equity (Quarterly) | -78.99M |
| Free Cash Flow to Firm (Quarterly) | -79.37M |
| Free Cash Flow Yield | -8.22% |